Drugs / MPL-005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05754840 | Jul 2025 → Dec 2026 expected | childhood malignant neoplasm | University of Manitoba | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MPL-005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05754840 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “cannabidiol-enriched cannabis herbal extract” NCT05754840 ↗ |